Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder [Phase 3]

View source ↗

Summary

A Phase 3 safety and efficacy trial of botulinum toxin type A for neurogenic overactive bladder was terminated, with results posted in January 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Overactive Bladder

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Overactive Bladder | Phase 3 | Status: TERMINATED | Results posted: 2014-01-24